heart disease
Heart failure mortality rates fall across England and Wales, national audit finds
August 11, 2017Medical Communications, Research and Development cardiovascular, heart, heart disease, life sciences, pharma, pharmaceutical
Great news in the cardiovascular space as results from the National Heart Failure Audit indicate that better treatment has led …
Heart disease drug development is falling
August 30, 2016Manufacturing and Production, Research and Development cardiovascular disease, heart disease, research and development
The number of drugs currently in development to combat heart disease has fallen in the last 20 years, it has …
Google and AHA to fund $50m cardiovascular disease project
November 13, 2015Medical Communications, Research and Development American Heart Association, cardiovascular disease, google, heart disease
The American Heart Association and Google Life Sciences have announced a joint research collaboration to bring ‘unconventional thinking’ to the …
NHS looks to ESC for next-gen heart drug data
August 28, 2015Medical Communications, Research and Development ALN-PCScs, Repatha, alirocumab, cardiology, cardiovascular disease, cvd, evolocumab, heart disease, high cholesterol, praluent
New data is expected to be presented at the European Cardiology Society congress in London, on the high cholesterol drugs …
First Apple ResearchKit app launches in the UK
August 7, 2015Medical Communications Apple, clinical trial, heart disease, researchkit, strokes
The first ResearchKit app to be made available to users outside of the US has launched in the UK. The …
Praluent scores positive trial results in Japan
July 9, 2015Research and Development Japan, PCKS9, Regeneron, Sanofi, heart disease, high cholesterol, praluent
Praluent, the new heart drug from Sanofi and Regeneron, has met its primary endpoint in a Phase III study in …
BMS enters gene therapy development deal
April 7, 2015Research and Development BMS, Bristol-Myers Squibb, R&D, cardiovascular disease, cvd, heart disease, heart failure, uniQure
Bristol-Myers Squibb (BMS) has signed a multi-million dollar agreement with Amsterdam-based gene therapy firm uniQure to boost research into new …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
